Home > Publications database > Elucidating the differential susceptibility of HNSCC to combined radiochemotherapy plus PARP inhibition
 
Poster (After Call) DKFZ-2024-02695
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Elucidating the differential susceptibility of HNSCC to combined radiochemotherapy plus PARP inhibition



2023

Wolfsberg Symposia, Hurdalsjøen Hotel,Hurdalsjøen Hotel,, Norway, 17 Jun 2023 - 19 Jun 20232023-06-172023-06-19  GO

Contributing Institute(s):
  1. E220 Radioonkologie Radiobiologie (E220)
Research Program(s):
  1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)
Click to display QR Code for this record

The record appears in these collections:
Document types > Presentations > Poster
Public records
Publications database
 Record created 2024-12-13, last modified 2024-12-16
Similar records



Rate this document:

Rate this document:
1
2
3
4
5
 
(Not yet reviewed)
DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.7 | join2_v2601a
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy